Hepatitis C New Drug Research And Liver Health
  • HCV News Of The Day
    • 2013/HCV Drugs News Digest
    • HCV Drugs: News Digest>
      • News Archive
      • Liver HCV : Specialty news digest
  • 2013 - Breaking Conference Reports/Hepatitis C
    • Breaking Conference Reports >
      • EASL 2012 Meeting Summary>
        • EASL Summary Of The 2011 March Meeting
      • AASLD- Nov 2011 Annual Meeting>
        • Conference Archive
  • Blog: New HCV Drug Updates
  • HCV FAQ
  • HCV: Newly Diagnosed?
    • Challenges-issues in managing hepatitis C
    • Ask Me A Question About Hepatitis C
  • What to do with a positive hepatitis C test
  • 2013-HCV Abstract Corner
    • HCV Abstract Corner>
      • Archive; Abstract Corner
  • 2013-Hepatitis C Full Text Articles
    • Hepatitis C Treatment Complete Studies 2012>
      • Potential new method to block the lifecycle of the Hepatitis C virus
      • Hepatitis C Treatment Complete Studies 2011
  • 2013/HCV Multimedia Videos Podcasts
    • Multimedia/Videos-Podcasts>
      • Watch How Hepatitis C Protease Inhibitors Work>
        • Multimedia; Archives Videos and Podcasts
  • 2013 Stem Cell News and Research
    • Liver-2012 Stem Cell Updates
    • Liver: 2011 Stem Cell Updates
    • What Are Stem Cells?>
      • Future applications of human stem cells
  • Recommended; Stem Cell Blogs
  • Understanding Hepatitis C
  • Natural History Of HCV
    • A 20-year cohort study on the natural history of untreated HCV infection
  • Hepatitis C Disease Progression
    • NIH scientists identify likely predictors of hepatitis C severity
    • HCV Epidemiology, Diagnosis and Disease Progression
    • Hepatitis C may increase deaths from both liver-related and other diseases>
      • Mortality in advanced HCV /long-term peginterferon
    • Host Factors on Management of HCV
  • Transmission
    • How Soon To Initiate HCV Therapy After Transmission
    • Does the Hepatitis C virus survive in dried blood ?
    • Viral Load Tied to Vertical Transmission of Hepatitis C
    • Hey Can I Get Hep C From......
    • HCV infections transmitted via a clinical setting
    • What Should I Do If I Get A Needlestick
  • How are the different types of hepatitis transmitted
    • New challenges in viral hepatitis
    • Hepatitis A virus infection in high-risk subjects
  • Your Liver Functions
  • Liver Function Tests
    • HCV-Persistently Normal (ALT) Alanine Aminotransferase Levels
    • Hey, I have a question about hcv tests and my liver
    • ALT used to separate those infected with HCV from those at low risk of liver disease
  • Lab Reports
  • HCV Viral Load Test
  • Liver Biopsy/Noninvasive Tests
    • Is there still a role for liver biopsy in managing hepatitis C virus infections?
    • Overview of Liver Biopsy Procedure
    • Three Algorithms of Non-invasive Markers of Fibrosis in Chronic Hepatitis C
    • FibroScan comparison to liver fibrosis biomarkers
  • Chronic HCV Symptoms
    • Fatigue and HCV
    • Sleep Disturbance in Chronic HCV
    • Skin Rash/Hepatitis C
    • Liver Disease: Bone Loss "It Ain't Like Menopause!"
  • HCV Neuropsychiatric symptoms-“brain fog”
    • HCV-Related Nervous System Disorders
    • Hepatitis C Virus and the Brain
    • Liver-induced inflammation hurts the brain
    • The Brain on Fire: Inflammation and Depression
  • Conditions Outside The Liver
    • Prevalence of fibromyalgia among patients with chronic hepatitis C
    • Lichen Planus and The Hepatitis C Virus
    • Dermatologic Disorders and Liver Disease
  • Chronic hepatitis C: Treat or wait?
    • Preparing For Treatment>
      • Starting Hepatitis C Treatment: Tips and Information 2011
      • Adherence To HCV Treatment-Review
      • Treating Hepatitis C; What can you do to increase your chance for SVR?
  • Hepatitis C advanced fibrosis: Treat or Wait
  • Approved Treatments for Hepatitis C
    • Adults:Treating Hepatitis C
    • Interferons and hepatitis C virus
  • HCV Treatment Failure Can Still Mean Less Liver Inflammation
  • 2013 - Current and Future Therapies for Hepatitis C
    • 2012 Future Prospects-Treatment of HCV>
      • Advances in the treatment of hepatitis C virus infection.
  • Protease inhibitors geno-1:New standard of care
    • Treating HCV Genotype 1 In The Real World
    • 2012 - Direct acting antivirals for the treatment of chronic hepatitis C
    • HCV:End of the Beginning-Possibly-Beginning of the End
    • Patients’ Expectations About New HCV Direct-Acting Antivirals Often Unrealistic
    • What Are NS5A inhibitors ?
    • Hepatitis C Treatment Nonresponders
    • New 2011 AASLD guidelines for treating HCV
    • Treating New and Old Therapies>
      • High-grade liver inflammation may predict treatment response
  • HCV Resistance To New And Experimental Drugs
    • Understanding Resistance in Chronic HCV Infection
  • Boceprevir & Telaprevir
    • FDA Telaprevir/Boceprevir Transcript
    • Pocket Guide Telaprevir/Boceprevir
    • Quick Facts- Direct-acting antivirals Telaprevir/Boceprevir
    • Telaprevir Or Boceprevir: What Is My Chance For A Cure?
  • 2013 News/Incivek (Telaprevir)
    • News/Telaprevir>
      • Telaprevir-IFN/ribavirin Hints at Response
      • Telaprevir FDA Approval>
        • Help-How Do I Take Incivek-telaprevir ?
        • Quick Study Of Telaprevir
        • Cost Of Treating With Telaprevir
  • 2013 News/Victrelis (Boceprevir)
    • News/ Boceprevir>
      • VICTRELIS-Boceprevir: Prescribing-Medication Guide
      • 2011;Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
      • 2011-Boceprevir for Untreated Chronic HCV Genotype 1 Infection
  • Side Effects-Interferon Free Therapies
  • Drug-Drug Interactions In Triple-Therapy
  • 2013/HCV Triple-therapy Side Effects
    • Boceprevir,Telaprevir Less Side Effects?>
      • 2013-HCV therapy geno 1: management of side-effects
      • Dry Mouth and Treatment >
        • Dry Mouth (Xerostomia)
      • Important updates to PegIntron labeling
      • Peginterferon alfa-2a Drug Interactions
      • HCV Treatment: Peginterferon and Ribavirin Side Effects
  • Genotypes/Treatment
    • Treatment Duration in Hepatitis C Virus Genotype 2/3-infected Patients
    • Impact of IL28B on Liver Histopathology in HCV Genotype 2/3
    • Genotype 3/HCV Treatment
    • HCV-Genotype 5 or 6
    • Hepatitis C-Genotype 4>
      • How to optimize HCV therapy in genotype 4 patients
      • Geno 4-Pioglitazone Decreases HCV Viral Load
    • Telaprevir/Boceprevir *genotype 1,2,3
    • (HCV) genotypes in the severity of liver disease
  • What Is The IL28B gene ?
    • Hepatitis C Test:Likelihood of achieving SVR>
      • IL28B and HCV immune responses
  • Index-Current Hepatitis C Drugs In Development
  • 2013-Interferon Free Combinations
    • Interferon-free combinations
    • 2013-Interferon free therapy w-direct acting antivirals for HCV
  • 2013 Sofosbuvir (GS-7977)
    • GS-7977-Formally PSI-7977 >
      • PSI-7977 peg/riba Geno 2/3 PROTON Trial
  • Sofosbuvir(GS7977)/Simeprevir(TMC435)
    • Interferon-Free Combo PSI-7977-TMC435
  • Sofosbuvir (GS-7977)/Ledipasvir (GS-5885)
  • GS-5885, an NS5A Inhibitor
  • ABT-450/r, ABT-267, ABT-333
  • Faldaprevir (BI 201335) and BI 207127 Interferon-Free
    • NS3/4A protease inhibitor BI201335
  • Miravirsen First MicroRNA-Targeted Drug
  • BMS-790052 (Daclatasvir)
  • Daclatasvir/VX135
  • ALS-2200 (VX-135)
  • BMS-790052/BMS-650032 Interferon-sparing
  • (TMC435) Simeprevir
  • TMC435 monotherapy in HCV genotypes 2-6
  • Simeprevir (TMC435) and TMC647055
  • Simeprevir,TMC647055 and IDX719
  • TMC435-daclatasvir-BMS-790052
  • Danoprevir-RG7227 direct-acting antiviral
  • Mericitabine- Polymerase Nuc
  • Sovaprevir (Formerly ACH-1625)
  • ACH-3102 NS5A inhibitor
  • INCIVEK, VX-222/Ribavirin
  • MK-5172 protease inhibitor
  • HCV/New Drug Pipeline
  • 2013/Hepatitis C Clinical Trials
    • Clinical Trials>
      • Learning About Clinical Trials
      • Boceprevir and Telaprevir Trials>
        • Telaprevir REALIZE STUDY
  • HCV Trials/Discontinued Or On Hold
    • Idenix IDX184-Hepatitis C drug
    • TMC435-BMS-986094-formerly INX-189
  • Women's Health; Treating Hepatitis C
    • Early Menopause and Response to HCV Treatment
  • Hepatitis C in Pregnancy
  • Treating Hepatitis C In Children
    • 2012 Hepatitis C infection in children
    • Autoimmunity/Extrahepatic Manifestations in HCV Treatment-Naïve Children
    • Study-long-term safety/durability of virologic response in paediatric patients who were previously treated w-interferon alfa-2b plus ribavirin for 48 weeks
  • Liver Disease in Elderly Patients
  • Dental considerations in patients with liver disease
    • HCV: Dental management-Diagnosis of extrahepatic manifestations>
      • Dental problems delaying the initiation of interferon
  • Fibrosis
    • Is there a natural way to improve liver fibrosis ?
  • 2013 News/Fibrosis
    • News: Fibrosis
  • Cirrhosis
    • What Is Cirrhosis ?
    • Advanced Liver Disease: What Every HCV Treater Should Know
    • The Patient With Cirrhosis: Don't Miss This
    • Hey, I have a question about cirrhosis
    • Physical Findings Suggestive Of Cirrhosis/Photos
    • Staging Cirrhosis>
      • When the Spleen Gets Tough, the Varices Get Going
    • Management Cirrhosis: How Are We Doing?
    • Cirrhosis Regression
    • Cirrhosis ; Surgery in the Patient with Liver Disease
    • Hepatic Encephalopathy>
      • Varices
      • Ascites
      • Management of ascites
  • 2013 News/Cirrhosis
    • News: Cirrhosis>
      • GI Bleeds: Withholding Transfusions Boosts Survival
  • Liver Transplant
    • New HCV Drugs:Expected Risks-Challenges in Liver Transplant
    • Prevention of hepatitis C recurrence after liver transplantation>
      • Effects of Telaprevir on Cyclosporine and Tacrolimus Pharmacokinetics Make Utility in Post-OLT Setting Uncertain
      • HCV Treatment After Liver Transplant
      • Antivirals Ineffective Against HCV After LT
  • 2013 News/Transplant
    • Liver Transplant News
  • Hepatocellular Carcinoma
    • Audio:Liver Cancer
    • Radioembolisation (RE),Selective Internal Radiation Therapy (SIRT)
    • Diagnosis (markers) of early hepatocellular carcinoma
    • Intrahepatic cholangiocarcinoma
    • Treatment TheraSphere/HCC/primary liver cancer
    • Liver Cancer : Microwave Ablation (MWA)
    • Pain May Predict Liver Cancer Prognosis
    • What Is the Indication for Sorafenib in Hepatocellular Carcinoma?
    • Liver Cysts and Tumors"Two Totally Different Concepts"
    • Interactive map of cancer mortality risk worldwide
  • 2013 News/Liver Cancer
    • Liver Cancer News and Updates
    • Vitamin E may lower liver cancer risk
  • Guidelines Nonalcoholic Fatty Liver Disease (NAFLD)
    • Fatty Liver And HCV>
      • Touching some firm ground in the epidemiology of NASH
      • Ultrasound/Liver Biopsy
      • Fatty Liver and Treatment
      • Liver fibrosis/Fatty Liver
  • 2013-Coffee and Liver Disease
  • Liver Regeneration
  • Liver Health
    • Choline: Great for the Liver
    • Medications for sleep in liver disease
    • The odds of gallbladder disease in Hepatitis C Patients
    • HCV & Gallbladder Disease:
    • Enlarged Spleen
    • HCV And Cardiovascular Risk
  • Nutrition-Herbs-Vitamins
    • Vitamin D and Treatment
    • Liver Disease - The Mediterranean Diet
    • Diet: Cirrhosis>
      • Low-Salt Diet-A Must in Cirrhosis
      • Diet for Liver Disease Low Sodium and More
      • Vitamin B12 supplements may help treat hepatitis
      • Nutrition in end-stage liver disease
      • Cirrhosis; Vitamin K Deficiencies
      • Vitamin D Levels In Cirrhosis
      • Vitamin D could de-stress Liver Disease Treatments
      • Drugs And Cirrhosis
      • Cancer and Berries
  • 2013-Silymarin for HCV infection
  • Milk Thistle
    • 2012-Milk Thistle No Help in Tough Hepatitis C Cases
    • Silymarin-Milk Thistle for NAFLD
    • Milk thistle"- Silibinin in hepatitis C related liver transplantation
    • Milk Thistle is coming to America
    • Caution! Herbs and Nutritional Supplements
  • HCV Drugs: Financial Support
  • HCV Filing For Social Security
  • Hepatitis C: A Rational Call To Arms
    • Hepatitis C; A Forced Legacy
    • Outsourcing:Globalization of the pharmaceutical industry>
      • Inspirational
  • Hepatitis C Links / Best On The Web
    • Chat and Message Boards
  • Whose Website Is This ?
  • Feedback/Contact Us

Nutrition for people with Cirrhosis

Picture
Diets for People With Cirrhosis

SODIUM AND HEPATITIS C

Advanced scarring of the liver (cirrhosis) may lead to an abnormal accumulation of fluid in the abdomen, referred to as ascites. Patients with HCV who have ascites must be on sodium (salt) restricted diets. Every gram of sodium consumed results in the accumulation of 200 ml. of fluid. The lower the salt content of the diet, the better this excessive fluid accumulation is controlled. Sodium intake should be restricted to 1,000 mg. a day or less. This requires careful shopping and reading all food labels. It is often surprising to discover which foods are high in sodium. For example, one ounce of corn flakes contains 350 mg. of sodium; one ounce of grated parmesan cheese, 528 mg. of sodium; one cup of chicken noodle soup, 1,108 mg. of sodium; and one teaspoon of table salt, 2,325 mg. of sodium. Avoid fast food restaurants, because most fast foods are high in sodium. Meats, especially red meats, are high in sodium, so meat consumption may need to be reduced and vegetarian alternatives considered. Patients with chronic HCV without ascites are advised not to overindulge in salt intake, although their restrictions need not be as severe.

At this stage the diet is generally high in complex carbohydrates (breads, cereals, grains, legumes, dried beans and peas, pasta, rice). These foods are important because they provide our bodies fuel source called blood glucose (also referred to as "blood sugar"). During cirrhosis, individuals frequently experience low blood sugar (hypoglycemia) or high blood sugar (hyperglycemia). Your body is better able to maintain a healthy, sustained level of energy from complex carbohydrates ("starches") rather than from simple carbohydrates ("sugars").

Think of your body as an automobile. Your body's "gasoline" is blood glucose. Sugars found in candy, fruits, sweet pastries, and milk products supply the body with "gasoline", but your body uses it quickly. The result is that your energy level usually rises and then falls too quickly with sugars than it would with complex carbohydrates, especially those with higher fiber content. This is not to say that simple sugar foods cannot be eaten, only in smaller proportion to complex carbohydrates and in more controlled portions.

You will also continue to need adequate, but not excessive protein in your diet (see When you discover you're Hepatitis C positive). Protein is needed for repair and maintenance of blood and body tissues, including liver tissue. Persons with cirrhosis tend to better tolerate the protein from dairy and plant sources than from meat sources, and therefore may benefit from a more vegetarian type diet. Daily protein needs in grams will vary according to your nutritional state. Your R.D. can give you more specific guidelines on this according to your body weight and the status of your disease.

Persons with cirrhosis often begin to experience difficulty digesting and absorbing fat in the diet. The result is steatorrhea, (the presence of undigested fat in the stool), and thereby may require dietary fat modification. Fatty liver is also a condition that can occur which is the accumulation of fat in the liver. In either of these cases, reducing the fat to 25% of total calories (about 40-70 grams of fat daily) is recommended. Use of a special prescription type of fat called MCT oil is sometimes necessary. MCT (medium-chain triglycerides) does not require bile for absorption into the blood stream, so is advantageous when the liver can no longer produce adequate bile for digestion and absorption of dietary fat (lipid). MCT can be used in place of other fats in cooking and some recipes and is also available in certain types of liquid nutritional drinks.

Therapeutic nutritional drinks now contain a mixture of MCT and other fats (called structured lipids). Using MCT alone can produce undesirable gastrointestinal complaints and is not indicated for the diabetic or significantly starved person. Structured lipids also have been found to enhance the immune system over other types of fats. Also, if MCT is the exclusive fat used in the diet, supplementation with the essential fatty acid called linoleic acid is required to prevent a dietary deficiency.

Vitamin deficiencies can occur during this stage of the disease. Fat-soluble vitamins A, D, E, and K may need to be taken in their water-soluble form by prescription from your doctor. Deficiencies of the minerals zinc, calcium, and magnesium can also occur during cirrhosis and may require supplementation. It is important that you do not take vitamins or minerals not prescribed by your doctor as toxicity can occur with overdosing. Sodium typically needs to be restricted with cirrhosis. Unfortunately for many salt lovers, this means learning to enjoy the taste of foods without salt. Since the taste for salt is acquired, it can also be lost, (usually taking 4-6 weeks of "biting the bullet" until you finally come to enjoy the many tastes of food, spices, and herbs without the salt shaker!)

Beware: many foods are high in sodium because of what's added in processing. Processed meats, cheeses, frozen dinners, canned soups and vegetables, snack chips and crackers can pack over 1000 milligrams of sodium per serving. Considering that the person with cirrhosis must usually limit sodium to 2,500 milligrams per day, these foods leave little room for other necessary, more healthy foods in the diet. Remember that sodium acts like a "sponge" in the body and can cause your body to hold on to more fluid, predisposing you to abdominal fluid retention seen in cirrhosis called ascites.


NUTRITIONAL MANAGEMENT:


Energy Requirements: Due to extreme weight loss in cirrhosis, energy requirements are increased.  A diet with 25-35 Kcal/Kg IBW (Ideal Body Weight) per day is recommended. Small and frequent meals should be given.

Carbohydrate Requirements: The carbohydrate content of the diet should be high in order to provide sufficient calories so that protein is not utilized for energy.  Also, the liver may store glycogen.  Liver function improves when an adequate store of glycogen is present in hepatocytes (liver cells).  Simple carbohydrates should be given, i.e., sugars, fruits juices, Sago, Arrowroot products, etc.  About 65-70 % of total calories should be provided by carbohydrates.

Protein Requirements: A liberal protein intake is essential for the repair of hepatic cells.  The serum albumin which is exclusively synthesized by the liver cells falls down in cirrhosis as a result of which there is water retention.  So, in order to maintain serum levels of albumin, it is necessary to take protein.  In case of absence of Hepatic Coma (a condition in which ammonia levels increases leading to brain tissue damage), 1.2 -1.5 gms per kg present body weight can be given.  Both animal and plant protein can be given.  Vegetable and dairy proteins are better tolerated because of their lower content of Aromatic Amino Acids (Methionine and Glutamine) and higher content of Branched chain Amino Acids (Valine, Leucine, and Isoleucine).  If protein requirements cannot be met by diet alone, then protein supplements can also be given.  However, if cirrhosis progresses to Hepatic Coma, then protein has to be totally restricted.

Fat Requirements: Cirrhosis is marked by impaired fat metabolism and absorption.  Triglycerides which contain Medium Chain Fatty Acids (8-10 CARBON FATTY ACIDS) like Ghee, Butter, etc. can be given.  These triglycerides do not require bile for their digestion and absorption.  This will help to prevent steatorrhea (fatty stools).  As the condition improves, large chain triglycerides can be given to avoid deficiency of essential fatty acids.

Vitamin Requirements: All of the vitamin should be supplied in abundance to fortify the liver against stress and to repair the damage.  Since the liver is involved in the synthesis of active forms of any B-complex vitamin and due to lack of proper function, it is advisable to give B-complex vitamin supplements.  In the presence of steatorrhea, water soluble forms of vitamin A, D, E, and K should be given.  In severe cirrhosis with problems of vitamin storage, metabolism, and transport intramuscular injections of Vitamin A, D, E, and K may be necessary.

Mineral Requirements: Iron intake should be increased to prevent anemia because the liver is unable to store iron in the form of ferritin.  Iron supplements can be given.  However, simultaneous increase of vitamin C is also required.  Calcium intake should also be increased.  Iron intake can be increased by following measures:

Increase the intake of Green leafy vegetables like Spinach, Mint, Methi, Amaranth etc.
Also, increase the intake of vitamin C.  So, consume lots of fresh fruits like Guava, Sweet Lime, Oranges, Aavla, etc.
Consume raw freshly sprouted pulses.  It can be consumed with salads too.
Consume Ragi (Nachni), soya bean flours. They can be mixed with wheat flour and chapatis can be made out of it.
Consume Rice flakes (Poha) as they are good source of iron.
Use jaggery instead of sugar, as jaggery is a good source of iron.
Soak 2-3 dates in water at night and then in the morning, consume it with milk or with water.
Sodium and Potassium Requirements: Sodium restriction is prescribed if edema (fluid retention in body) is present.  Sodium is restricted to 2 gm per day.  At the same time, potassium intake is increased.  Some potassium-rich foods are coconut water, water obtained after boiling Moong Dal, Amla, Guava, Sapota, Papaya, Sweet lime, Peaches, Phalsa, Plums, and Gourd vegetables like Lauki, Karela, Turai, etc.

In order to make food palatable even with less salt one should make use of pepper powder, lemon juice, etc.  Also, avoid food items like Jam, Canned fruits, Sauces, Pickles, Papads, Salted biscuits, Salted dry fruits, Cheese, Butter, Potato chips, and fruits like Lichi, Pineapple.  Due to restriction of salt, the food becomes less palatable and therefore the patient becomes irritable.  However, we can make food palatable if we follow the following tips:

Make the food look attractive, so garnish well.  Can use coriander leaves, tomato slices, onions, etc.  Use Ratanjot for natural red color. Ratanjot is a herb which gives bright red color.  Make vagaar with Ratanjot, it will give bright red color to food.  Can add Ratanjot in Dal, sabzi, pulav, etc.
Always serve food hot.  When food is consumed hot, one does not feel that there is less salt in food.  So, serve soups, dal, sabzi hot and ask the patient to consume it hot only.
Squeeze lemon juice from top just before serving food.  This will curb the need of salt in food.
Add jeera powder and/or black pepper and/or mango powder to food.  This will make food tasty even with less salt.
Serve food in attractive vessels.
Fluid Requirement: In case of edema, fluid restriction is necessary.  Total fluid intake equals to urinary output + 500 ml.

Alcohol Intake: Alcohol intake should be completely restricted.  Even a single drop can be deadly.




 


Copyright 2010-2013 Hepatitis C New Drug Research And Liver Health